<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> (HH) has been associated with cardiovascular and <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> and oxidative cell damage </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are associated with <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> (AI) and increased <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We tested the association of HH and <z:mp ids='MP_0003674'>oxidative stress</z:mp> in 33 MDS patients, by measuring plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>HH was found in 42% of cases, (4/5) cases with associated cardiovascular events (CVE)(80%), and 9/15 cases with associated AI (60%) </plain></SENT>
<SENT sid="4" pm="."><plain>Thus in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, HH was significantly associated with AI/CVE (chi(2) : p=0.0011), and this association seems to be specific, as demonstrated by the comparison of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> presenting AI/CVE with the ischemic <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiopathy</z:e>/<z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> control group (13/20, 65% vs 19/69, 27%; chi(2) : p=0.0021) </plain></SENT>
<SENT sid="5" pm="."><plain>The levels of <z:chebi fb="14" ids="32506">MDA</z:chebi> indicated increased <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Our data may suggest that in a subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, HH may simultaneously contribute to bone marrow <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>, CVE and AI pathogenesis, possibly through oxidative cell damage </plain></SENT>
</text></document>